Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2005
10/26/2005EP1588726A1 Drug/drug delivery systems for the prevention and treatment of vascular disease
10/26/2005EP1588717A1 PEG-LHRH analog conjugates
10/26/2005EP1588716A1 Peg-urate oxidase conjugates and use thereof
10/26/2005EP1588715A1 Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the same
10/26/2005EP1588707A1 Stable solid medicinal composition for oral administration
10/26/2005EP1588706A2 Use of AT1 receptor antagonists or AT2 receptor modulator for the treatment of conditions or diseases associated with the increase of AT1 or AT2 receptors.
10/26/2005EP1588702A1 Azalide antibiotics for the topical treatment or prevention of ocular infections
10/26/2005EP1588701A2 Rapidly-decomposing dosage form for releasing nicotine in the oral cavity or in bodily cavities
10/26/2005EP1588700A1 Biofunctional polymers prepared in supercritical fluid
10/26/2005EP1588699A2 Container with multi-phase composition for use in diagnostic and therapeutic applications
10/26/2005EP1588697A1 Emulsion gel for topical application of pharmaceuticals
10/26/2005EP1588692A1 Durable foamed composition
10/26/2005EP1588629A1 Matrix-forming composition containing pectin
10/26/2005EP1588162A2 Hsc70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease
10/26/2005EP1587954A1 Solid surface for biomolecule delivery and high-throughput assay
10/26/2005EP1587945A2 Hydroxyphenyl cross-linked macromolecular network and applications thereof
10/26/2005EP1587869A2 Membrane active polymers
10/26/2005EP1587843A2 Combinatorial libraries of monomer domains
10/26/2005EP1587550A2 Methods and compositions for administering therapeutic and diagnostic agents
10/26/2005EP1587548A1 Echogen microparticles essentially used as a contrast agent for ultrasound exploration and/or as emboli for ultrasound detection
10/26/2005EP1587543A1 Calcium phosphate ceramics and particles for in vivo and in vitro transfection
10/26/2005EP1587536A1 Agents for the diagnosis and treatment of tumours that expose altered proteins on the cell surface
10/26/2005EP1587525A2 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus
10/26/2005EP1587524A2 Compositions and methods for targeted biological delivery of molecular carriers
10/26/2005EP1587517A1 Anti-protozoal compositions comprising diclazuril
10/26/2005EP1587484A2 Method of treating angiogenic tissue growth
10/26/2005EP1587375A1 Novel compositions comprising carotenoids
10/26/2005EP1534213A4 Water-based delivery systems
10/26/2005EP1534072A4 Anthelmintic oral homogeneous veterinary pastes
10/26/2005EP1463492B1 Adhesive and binding agent for dermal or transdermal treatment systems
10/26/2005EP1444264A4 Methods and materials for targeting and affecting selected cells
10/26/2005EP1423109B1 Compositions comprising pectin and ascorbic acid
10/26/2005EP1397133B1 Rapid onset formulation
10/26/2005EP1395224A4 Tamper resistant oral dosage form
10/26/2005EP1368001B1 Pharmaceutical formulation comprising bicalutamide
10/26/2005EP1365713B1 Urine incontinence device
10/26/2005EP1361881B1 Steroid hormone products and methods for preparing them
10/26/2005EP1280507B1 Eutectic mixtures in cosmetic compositions
10/26/2005EP1265618B1 Anaesthetic compositions comprising alfaxalone
10/26/2005EP1263392B1 Clear water-in-oil emulsions
10/26/2005EP1212092B1 High viscosity liquid controlled delivery system and medical or surgical device
10/26/2005EP1163234B1 Pharmaceutical formulations with improved aqueous solubility
10/26/2005EP1140148B1 Shelf-stable solution formulation of glucagon-like peptide-1
10/26/2005EP1107762B1 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure sexual dysfunction in women
10/26/2005EP1087778B1 Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c
10/26/2005EP1082107B1 Controlled release lipoic acid
10/26/2005EP1073415B1 Pharmaceutical compositions capable of being gelled
10/26/2005EP0975357B1 Transdermal delivery system
10/26/2005CN1688702A Use of recombinant measles viruses expressing epitopes of antigens of RNA viruses in the preparation of vaccine compositions
10/26/2005CN1688572A Piperidinyl targeting compounds that selectively bind integrins
10/26/2005CN1688529A Alkoxylates exhibiting low residual alcohol content
10/26/2005CN1688345A Composition with stabilized redox properties and method of stabilization of redox properties
10/26/2005CN1688343A Modified saccharides, conjugates thereof, and their manufacture
10/26/2005CN1688321A Composition for treating hemorrhoids
10/26/2005CN1688313A Orally dispersible pharmaceutical piribedil composition
10/26/2005CN1688292A Taste masked dosage forms and processes for their preparation
10/26/2005CN1688291A Immediate release dosage forms containing solid drug dispersions
10/26/2005CN1688270A Topical patch and reagent kit containing a delayed-type hypersensitivity inducer
10/26/2005CN1687118A Cyclic peptide containing arginine, glycine, asparagicacid-sequence and active target liposome
10/26/2005CN1686562A Composition of transiron protein and biological reducing agent and its preparation method
10/26/2005CN1686561A Modified natural polymer medical adjuvant, its preparation method and use
10/26/2005CN1686560A Chitin tetra ammonium salt nano-particle, its preparation method and use
10/26/2005CN1686559A Chitose composition for promoting medicine transfer through skin penetration and its use method
10/26/2005CN1686558A Chromium supplementing agent using palygorskite or montmorillonite as carrier, its preparation and use method
10/26/2005CN1686557A Calcium sulphate based embedded type local medicine releasing system and preparation method
10/26/2005CN1686549A Medicinal composition for treating high blood pressure
10/26/2005CN1224424C Thermosetting medical carrier composition with mucosa adsorption
10/26/2005CN1224423C Pharmaceutical composition improved in peroral absorbability
10/26/2005CN1224388C Modified prodrug forms of ap/amp
10/26/2005CN1224381C Method for prepaing fast-dispersing dosage forms containing fish gelatin
10/26/2005CN1224380C Method for reducing residual organic solvent in microparticles and use in preparation of medicine thereof
10/26/2005CN1224379C Liquisolid system and method of preparing the same
10/26/2005CN1224373C Method for preparing base oil for cosmetic
10/25/2005US6958411 Antitumor agent; viricide
10/25/2005US6958326 Estrogen complexes; stabilization
10/25/2005US6958325 Biodegradabel polysaccharide derivative for use in human therapeutic and diagnostics
10/25/2005US6958318 Recombinant bacterial cells for delivery of PNP to tumor cells
10/25/2005US6958241 Liposomes with outer surfaces having an affinity moiety that binds to a biological therapy target surface, and a hydrophilic polymer coating reversibly conjugated to said moiety; e.g. polymyxin B conjugate liposome for septic shock
10/25/2005US6958240 Inhibition of major groove DNA binding proteins by modified polyamides
10/25/2005US6958212 coupling of a pharmaceutically active compound to a polymer using a conjugate addition reaction, and the cross-linking of the polymer to form a biomaterial, in some embodiments using conjugate addition reactions; controlled release of drug
10/25/2005US6958160 liposomes include diacylglycerol-PEG compounds; melting point below about 40 degrees C, and acyl chains greater than or equal to 14 carbons in length; use in drug delivery, diagnostics, cosmetics, cosmeceuticals and nutraceuticals
10/25/2005US6958159 Pharmaceutical gel composition
10/25/2005US6958158 Immune modulation device for use in animals
10/25/2005US6958154 Tacky component of an adhesive, and a film-forming, non-tacky component that are immiscible with each other to undergo phase separation
10/25/2005US6958153 topical formulation of azithromycin / clarithromycin macrocyclic lactone antibiotic or Tacrolimus/ Sirolimus immunosuppressive macrolide and permeation modulator; minimizes systemic exposure treating at site reduced side effects; scalp conditions
10/25/2005US6958148 microparticle comprising active agent and polymer having transglutaminase substrate reactive groups, wherein reactive groups are surface available, and polymer comprises amino acids having at least three contiguous linked glutamines; drug delivery
10/25/2005US6958143 Aftersmoking; converting nicotine to cotinine; discharing in urine
10/25/2005US6958142 Nasal spray formulation and method
10/25/2005CA2440764C Combination of brimonidine and timolol for topical ophthalmic use
10/25/2005CA2329172C Storage stable extended release oral dosage composition comprising desloratadine and pseudoephedrine
10/25/2005CA2298238C Controlled release by extrusion of solid amorphous dispersions of drugs
10/25/2005CA2227887C Pharmaceutical compositions of conjugated estrogens and methods for their use
10/25/2005CA2197865C Oestradiol-containing transdermal therapeutic system comprising hydrophylic additives
10/21/2005CA2504582A1 Drug delivery device comprising a bilayered polymeric coating having an inhibitor of the mamalian target of rapamycin incorporated into the first polymeric coating layer
10/21/2005CA2504401A1 Drug delivery systems for the prevention of neointimal hyperlasia
10/20/2005WO2005097871A1 Pseudo-thermosetting neutralized chitosan composition forming a hydrogel and a process for producing the same
10/20/2005WO2005097869A1 Polymers comprising ion channel modulating compounds and uses thereof
10/20/2005WO2005097677A1 Embolization
10/20/2005WO2005097672A2 Method for the production of carbon nanotubes that are ferromagnetically filled in part and carry biomolecules, and use thereof in diagnosis and therapy
10/20/2005WO2005097225A1 New viscoelastic composition, method of use and package